Addus Net Income From Continuing Ops from 2010 to 2026
| ADUS Stock | USD 102.15 -0.71 -0.69% |
Net Income From Continuing Ops | First Reported 2007-12-31 | Previous Quarter 22.8 M | Current Value 29.8 M | Quarterly Volatility 7.2 M |
Addus | Net Income From Continuing Ops | Build AI portfolio with Addus Stock |
Latest Addus HomeCare's Net Income From Continuing Ops Growth Pattern
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Addus Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 32,975,206 | |
| Geometric Mean | 19,819,166 | |
| Coefficient Of Variation | 97.79 | |
| Mean Deviation | 26,043,654 | |
| Median | 17,377,000 | |
| Standard Deviation | 32,245,052 | |
| Sample Variance | 1039.7T | |
| Range | 102.7M | |
| R-Value | 0.93 | |
| Mean Square Error | 154T | |
| R-Squared | 0.86 | |
| Slope | 5,925,498 | |
| Total Sum of Squares | 16635.9T |
Addus Net Income From Continuing Ops History
About Addus HomeCare Corporation
Methodology
Unless otherwise specified, financial data for Addus HomeCare is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Addus (USA Stocks:ADUS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Addus HomeCare is covered by 14 analysts. 7 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Goldman Sachs, BMO Capital Markets, HSBC Global Research, Guggenheim Securities, Barclays, Oppenheimer & Co., Evercore ISI, Citigroup, among others. Updates may occur throughout the day.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Addus Stock Analysis
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |